Protein S levels and the risk of venous thrombosis: Results from the MEGA case-control study

Blood

Volumn 122, Issue 18, 2013, Pages 3210-3219

  Pintao, Maria Carolina ^a   Ribeiro, Daniel D ^a,b   Bezemer, Irene D ^a   Garcia, Andrea A ^a   De Visser, Marieke C H ^a   Doggen, Carine J M ^a,c   Lijfering, Willem M ^a   Reitsma, Pieter H ^a,c   Rosendaal, Frits R ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^c UNIVERSITY OF TWENTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN S;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; COPY NUMBER VARIATION; FEMALE; GENE MUTATION; GENE SEQUENCE; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; PROTEIN S DEFICIENCY; RARE DISEASE; VEIN THROMBOSIS;

EID: 84888223753     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2013-04-499335     Document Type: Article

References (43)

1. Fair DS, Marlar RA. Biosynthesis and secretion of factor VII, protein C, protein S, and the Protein C inhibitor from a human hepatoma cell line. Blood. 1986;67(1):64-70.
2. Dahlbäck B. The tale of protein S and C4b-binding protein, a story of affection. Thromb Haemost. 2007;98(1):90-96.
3. Walker FJ. Protein S and the regulation of activated protein C. Semin Thromb Hemost. 1984;10(2):131-138.
4. Hackeng TM, Seré KM, Tans G, Rosing J. Protein S stimulates inhibition of the tissue factor pathway by tissue factor pathway inhibitor. Proc Natl Acad Sci USA. 2006;103(9):3106-3111.
5. Castoldi E, Maurissen LF, Tormene D, et al. Similar hypercoagulable state and thrombosis risk in type I and type III protein S-deficient individuals from families with mixed type I/III protein S deficiency. Haematologica. 2010;95(9):1563-1571.
6. Boyer-Neumann C, Bertina RM, Tripodi A, et al. Comparison of functional assays for protein S: European collaborative study of patients with congenital and acquired deficiency. Thromb Haemost. 1993;70(6):946-950.
7. Gandrille S, Borgel D, Sala N, et al; Plasma Coagulation Inhibitors Subcommittee of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Protein S deficiency: a database of mutations-summary of the first update. Thromb Haemost. 2000;84(5):918.
8. García De Frutos P, Fuentes-Prior P, Hurtado B, Sala N. Molecular basis of protein S deficiency. Thromb Haemost. 2007;98(3):543-556.
9. Stenson PD, Mort M, Ball EV, et al. The Human Gene Mutation Database: 2008 update. Genome Med. 2009;1(1):13.
10. Johansson AM, Hillarp A, Säll T, Zöller B, Dahlbäck B, Halldén C. Large deletions of the PROS1 gene in a large fraction of mutationnegative patients with protein S deficiency. Thromb Haemost. 2005;94(5):951-957.
11. Pintao MC, Garcia AA, Borgel D, et al. Gross deletions/duplications in PROS1 are relatively common in point mutation-negative hereditary protein S deficiency. Hum Genet. 2009;126(3):449-456.
12. Makris M, Leach M, Beauchamp NJ, et al. Genetic analysis, phenotypic diagnosis, and risk of venous thrombosis in families with inherited deficiencies of protein S. Blood. 2000;95(6):1935-1941.
13. Ten Kate MK, Platteel M, Mulder R, et al. PROS1 analysis in 87 pedigrees with hereditary protein S deficiency demonstrates striking genotypephenotype associations. Hum Mutat. 2008;29(7):939-947.
14. Lijfering WM, Mulder R, Ten Kate MK, Veeger NJ, Mulder AB, Van Der Meer J. Clinical relevance of decreased free protein S levels: results from a retrospective family cohort study involving 1143 relatives. Blood. 2009;113(6):1225-1230.
15. Vossen CY, Conard J, Fontcuberta J, et al. Risk of a first venous thrombotic event in carriers of a familial thrombophilic defect. The European Prospective Cohort on Thrombophilia (EPCOT). J Thromb Haemost. 2005;3(3):459-464.
16. Vossen CY, Walker ID, Svensson P, et al. Recurrence rate after a first venous thrombosis in patients with familial thrombophilia. Arterioscler Thromb Vasc Biol. 2005;25(9):1992-1997.
17. Lijfering WM, Brouwer JL, Veeger NJ, et al. Selective testing for thrombophilia in patients with first venous thrombosis: results from a retrospective family cohort study on absolute thrombotic risk for currently known thrombophilic defects in 2479 relatives. Blood. 2009;113(21):5314-5322.
18. Zöller B, Berntsdotter A, García De Frutos P, Dahlbäck B. Resistance to activated protein C as an additional genetic risk factor in hereditary deficiency of protein S. Blood. 1995;85(12):3518-3523.
19. Faioni EM, Valsecchi C, Palla A, Taioli E, Razzari C, Mannucci PM. Free protein S deficiency is a risk factor for venous thrombosis. Thromb Haemost. 1997;78(5):1343-1346.
20. Koster T, Rosendaal FR, Briët E, et al. Protein C deficiency in a controlled series of unselected outpatients: an infrequent but clear risk factor for venous thrombosis (Leiden Thrombophilia Study). Blood. 1995;85(10):2756- 2761.
21. Liberti G, Bertina RM, Rosendaal FR. Hormonal state rather than age influences cut-off values of protein S: reevaluation of the thrombotic risk associated with protein S deficiency. Thromb Haemost. 1999;82(3):1093-1096.
22. Blom JW, Doggen CJ, Osanto S, Rosendaal FR. Malignancies, prothrombotic mutations, and the risk of venous thrombosis. JAMA. 2005;293(6):715-722.
23. Borgel D, Duchemin J, Alhenc-Gelas M, Matheron C, Aiach M, Gandrille S; The French Network on Molecular Abnormalities Responsible for Protein C and Protein S Deficiencies. Molecular basis for protein S hereditary deficiency: genetic defects observed in 118 patients with type I and type IIa deficiencies. J Lab Clin Med. 1996;128(2):218-227.
24. Schouten JP, McElgunn CJ, Waaijer R, Zwijnenburg D, Diepvens F, Pals G. Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. Nucleic Acids Res. 2002;30(12):e57.
25. Mulder R, Van Schouwenburg IM, Mahmoodi BK, et al. Associations between high factor VIII and low free protein S levels with traditional arterial thrombotic risk factors and their risk on arterial thrombosis: results from a retrospective family cohort study. Thromb Res. 2010;126(4):e249-e254.
26. Henkens CM, Bom VJ, Van Der Schaaf W, Pelsma PM, Sibinga CT, De Kam PJ, Van Der Meer J. Plasma levels of protein S, protein C, and factor X: effects of sex, hormonal state and age. Thromb Haemost. 1995;74(5):1271-1275.
27. Knol MJ, Vandenbroucke JP, Scott P, Egger M. What do case-control studies estimate? Survey of methods and assumptions in published casecontrol research. Am J Epidemiol. 2008;168(9):1073-1081.
28. Middeldorp S, Meijers JC, Van Den Ende AE, et al. Effects on coagulation of levonorgestreland desogestrel-containing low dose oral contraceptives: a cross-over study. Thromb Haemost. 2000;84(1):4-8.
29. Said JM, Ignjatovic V, Monagle PT, Walker SP, Higgins JR, Brennecke SP. Altered reference ranges for protein C and protein S during early pregnancy: Implications for the diagnosis of protein C and protein S deficiency during pregnancy. Thromb Haemost. 2010;103(5):984-988.
30. Bezemer ID, Van Der Meer FJ, Eikenboom JC, Rosendaal FR, Doggen CJ. The value of family history as a risk indicator for venous thrombosis. Arch Intern Med. 2009;169(6):610-615.
31. Mulder R, Ten Kate MK, Kluin-Nelemans HC, Mulder AB. Low cut-off values increase diagnostic performance of protein S assays. Thromb Haemost. 2010;104(3):618-625.
32. Ten Kate MK, Van Der Meer J. Protein S deficiency: a clinical perspective. Haemophilia. 2008;14(6):1222-1228.
33. Brouwer JL, Lijfering WM, Ten Kate MK, Kluin-Nelemans HC, Veeger NJ, Van Der Meer J. High long-term absolute risk of recurrent venous thromboembolism in patients with hereditary deficiencies of protein S, protein C or antithrombin. Thromb Haemost. 2009;101(1):93-99.
34. Tans G, Curvers J, Middeldorp S, et al. A randomized cross-over study on the effects of levonorgestrel- and desogestrel-containing oral contraceptives on the anticoagulant pathways. Thromb Haemost. 2000;84(1):15-21.
35. Hansen AT, Andreasen BH, Salvig JD, Hvas AM. Changes in fibrin D-dimer, fibrinogen, and protein S during pregnancy. Scand J Clin Lab Invest. 2011;71(2):173-176.
36. Ken-Dror G, Cooper JA, Humphries SE, Drenos F, Ireland HA. Free protein S level as a risk factor for coronary heart disease and stroke in a prospective cohort study of healthy United Kingdom men. Am J Epidemiol. 2011;174(8):958-968.
37. Toulon P, Gandrille S, Vitoux JF, Fiessinger JN, Sultan Y, Aiach M. High total and free protein S in patients with acute deep vein thrombosis. Thromb Res. 1990;59(1):213-217.
38. Darvall KA, Sam RC, Silverman SH, Bradbury AW, Adam DJ. Obesity and thrombosis. Eur J Endovasc Surg. 2007;33(2):223-233.
39. Goodwin AJ, Rosendaal FR, Kottke-Marchant K, Bovill EG. A review of the technical, diagnostic, and epidemiologic considerations for protein S assays. Arch Pathol Lab Med. 2002;126(11):1349-1366.
40. Gandrille S, Borgel D, Eschwege-Gufflet V, et al. Identification of 15 different candidate causal point mutations and three polymorphisms in 19 patients with protein S deficiency using a scanning method for the analysis of the protein S active gene. Blood. 1995;85(1):130-138.
41. Espinosa-Parrilla Y, Yamazaki T, Sala N, Dahlbäck B, De Frutos PG. Protein S secretion differences of missense mutants account for phenotypic heterogeneity. Blood. 2000;95(1):173-179.
42. Rezende SM, Lane DA, Zöller B, Mille-Baker B, Laffan M, Dalhbäck B, Simmonds RE. Genetic and phenotypic variability between families with hereditary protein S deficiency. Thromb Haemost. 2002;87(2):258-265.
43. Den Dunnen JT, Antonarakis SE. Mutation nomenclature extensions and suggestions to describe complex mutations: a discussion. Hum Mutat. 2000;15(1):7-12.